Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
absence, Addendum, affiliate, appraisal, chartered, Citigroup, compulsory, Computershare, consummate, consummated, consummation, Crimson, Cuban, CVR, GSK, hypothesize, intragroup, issuable, Kingdom, longevity, mail, Mark, Merger, mix, Morgan, nationwide, par, PAS, PBC, promptly, properly, quotient, relapsed, restraining, restraint, shelf, specialty, stipulation, subsidiary, surviving, thereof, treasury, underwriting, Union, upward, weighted
Removed:
Asia, Avastin, bevacizumab, bioequivalence, Colorado, contracting, crossover, enhanced, ERP, fear, fifteen, function, governor, imposing, indefinite, Innovent, internalization, invalidating, lawfully, live, Onpro, pharmacodynamic, PK, proceed, protracted, quarantining, randomized, receptor, recommended, regime, reinstatement, Shield, Southeast, strained, Suzhou, timeline, upgrade, Utah, Virginia
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view